Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities:
Net loss	$ (13,573,833)	$ (5,333,785)
Adjustments to reconcile net loss to cash used in operating activities:
Depreciation and amortization	6,068,341	2,295,116
Amortization of debt issuance costs	811,620	587,688
Stock based compensation expense related to issuance of restricted stock	9,684	12,912
Accretion of preferred equity costs	189,920
Derivative fair value adjustment	104,453
Unrealized foreign currency adjustment	(598,510)	163,835
Changes in operating assets and liabilities:
Other assets, net	(1,392,461)	(217,628)
Purchase of interest rate cap	(1,878,000)
Accounts payable and accrued liabilities	1,265,754	750,254
Due to affiliates	266,515	(194,024)
Net cash used in operating activities	(8,726,517)	(1,935,632)
Cash flows from investing activities:
Purchase of real estate facilities	(250,502,233)	(107,891,695)
Additions to real estate facilities	(3,576,484)	(293,960)
Deposits on acquisitions of real estate facilities	(74,210)	(160,000)
Investment in company owned life insurance	(911,541)
Investments in unconsolidated real estate ventures	(2,810,299)	(259,972)
Net cash used in investing activities	(257,874,767)	(108,605,627)
Cash flows from financing activities:
Proceeds from issuance of secured debt	179,324,261	88,637,702
Repayment of secured debt	(50,000,000)	(30,608,851)
Scheduled principal payments of secured debt	(545,444)
Prepaid debt issuance costs	(42,000)
Debt issuance costs	(1,415,112)	(1,100,911)
Gross proceeds from issuance of common stock	19,855,323	67,831,027
Offering costs	(1,929,766)	(6,193,648)
Proceeds from issuance of preferred equity in our Operating Partnership	15,000,000
Redemption of preferred equity in our Operating Partnership	(15,000,000)
Preferred equity in our Operating Partnership issuance costs	(189,920)
Gross proceeds from issuance of preferred stock	150,000,000
Preferred stock issuance costs	(1,400,277)
Redemption of common stock	(22,508)
Distributions paid to common stockholders	(2,910,055)	(1,279,865)
Distributions paid to noncontrolling interest in our Operating Partnership	(170,046)	(146,383)
Distributions paid to preferred unitholders in our Operating Partnership	(271,250)
Net cash provided by financing activities	290,283,206	117,139,071
Impact of foreign exchange rate changes on cash and restricted cash	(549,047)
Net change in cash, cash equivalents and restricted cash	23,132,875	6,597,812
Cash, cash equivalents and restricted cash, beginning of period	7,791,544	4,580,759
Cash, cash equivalents and restricted cash, end of period	30,924,419	11,178,571
Supplemental disclosures and non-cash transactions:
Cash paid for interest	7,204,354	839,672
Real estate facilities in due to affiliates	2,567,640
Real estate facilities in accounts payable and accrued liabilities	60,000
Real estate and construction in process in accounts payable and accrued liabilities	941,124
Debt issuance costs in due to affiliates	150,000
Debt issuance costs in accounts payable and accrued liabilities	49,082
Proceeds from issuance of common stock in accounts payable and accrued liabilities	(176,400)	(1,124,000)
Offering costs included in accounts payable and accrued liabilities	546,652	466,781
Interest rate swap contracts in other assets	1,994,683
Foreign currency translation adjustment	312,946
Issuance of shares pursuant to distribution reinvestment plan	2,053,882	889,649
Distributions payable to common stockholders	875,259	561,217
Distributions payable to noncontrolling interests in our Operating Partnership	28,030	$ 27,134
Distributions payable to Preferred stockholders	2,087,500
Redemption of common stock in accounts payable and accrued liabilities	155,516
Deposits applied to acquisition of real estate	$ 220,000